- Home
- TIL vs MYO Comparison
TIL vs MYO Comparison
Compare TIL & MYO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TIL
- MYO
- Stock Information
- Founded
- TIL 2018
- MYO 2004
- Country
- TIL United States
- MYO United States
- Employees
- TIL N/A
- MYO N/A
- Industry
- TIL Biotechnology: Pharmaceutical Preparations
- MYO Industrial Specialties
- Sector
- TIL Health Care
- MYO Health Care
- Exchange
- TIL Nasdaq
- MYO Nasdaq
- Market Cap
- TIL 171.7M
- MYO 153.0M
- IPO Year
- TIL 2021
- MYO 2017
- Fundamental
- Price
- TIL $15.46
- MYO $4.37
- Analyst Decision
- TIL Buy
- MYO Strong Buy
- Analyst Count
- TIL 5
- MYO 4
- Target Price
- TIL $114.00
- MYO $9.75
- AVG Volume (30 Days)
- TIL 78.2K
- MYO 301.7K
- Earning Date
- TIL 05-09-2025
- MYO 05-07-2025
- Dividend Yield
- TIL N/A
- MYO N/A
- EPS Growth
- TIL N/A
- MYO N/A
- EPS
- TIL N/A
- MYO N/A
- Revenue
- TIL N/A
- MYO $32,551,198.00
- Revenue This Year
- TIL N/A
- MYO $32.15
- Revenue Next Year
- TIL N/A
- MYO $17.59
- P/E Ratio
- TIL N/A
- MYO N/A
- Revenue Growth
- TIL N/A
- MYO 69.17
- 52 Week Low
- TIL $9.62
- MYO $2.51
- 52 Week High
- TIL $92.00
- MYO $7.17
- Technical
- Relative Strength Index (RSI)
- TIL 44.19
- MYO 40.76
- Support Level
- TIL $14.96
- MYO $4.21
- Resistance Level
- TIL $18.71
- MYO $4.62
- Average True Range (ATR)
- TIL 1.80
- MYO 0.34
- MACD
- TIL 0.09
- MYO -0.01
- Stochastic Oscillator
- TIL 46.32
- MYO 41.34
About TIL Instil Bio Inc.
Instil Bio Inc is a clinical-stage biopharmaceutical company focused on developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte, or TIL, therapies for the treatment of patients with cancer. It is also engaged in developing a novel class of genetically engineered TIL therapies using its Co-Stimulatory Antigen Receptor, or CoStAR, platform. Its pipeline includes ITIL-306 which expresses a CoStAR molecule designed to recognize FRα, a tumor-associated antigen that is expressed on numerous solid tumors, including ovarian cancer, uterine cancer, NSCLC, and renal cancer.
About MYO Myomo Inc.
Myomo Inc is a wearable medical robotics company that develops, designs, and produces myoelectric orthotics for people with neuromuscular disorders. The MyoPro myoelectric upper limb orthosis product is registered with the Food and Drug Administration as a Class II medical device. The company provides the devices to patients and bills their insurance companies directly, sometimes utilizing the clinical services of orthotics and prosthetics providers for which a fee is paid. The company sells the product to orthotics and prosthetics providers around the world and the Veterans Health Administration (VA).